Welcome to our dedicated page for Relativity Acquisition news (Ticker: ACQC), a resource for investors and traders seeking the latest updates and insights on Relativity Acquisition stock.
Relativity Acquisition Corp. reports news centered on SPAC and security-structure matters. Recurring developments include material agreements, stockholder voting matters, charter and redemption-related proposals, capital-structure disclosures, governance matters, risk factors, and operating and financial results.
The company's news profile reflects its status as a blank-check issuer rather than an operating company. Updates generally relate to the business-combination process, shareholder approvals, public security-holder mechanics, and reporting obligations associated with a SPAC structure.
Relativity Acquisition Corp (OTC: ACQC) announced that shareholders approved a business combination with Instinct Brothers on March 25, 2026. The companies expect the deal to close in the coming weeks, subject to customary closing conditions, and the combined company will be named Instinct Bio Technical Company Holdings Inc with Nasdaq symbols BIOT and BIOTW.
A Form 8-K with full voting results will be filed with the SEC in the coming days.
Relativity Acquisition Corp (OTC: ACQC) shareholders approved a business combination with Instinct Bio Technical Company Inc (Instinct Brothers) on March 24, 2026.
The companies expect the transaction to close in the coming weeks, subject to closing conditions, after filing a Form 8-K with the SEC. Upon closing the combined company is expected to be named Instinct Bio Technical Company Holdings Inc with Nasdaq symbols BIOT and BIOTW.
Relativity Acquisition Corp (OTC: ACQC) and Instinct Brothers scheduled an Extraordinary General Meeting of Relativity shareholders for March 25, 2026 at 9:30 a.m. ET to vote on the previously announced business combination.
The SEC has declared effective the Form F-4 Registration Statement and Relativity will mail the definitive proxy statement/prospectus to shareholders of record as of February 25, 2026. If closing conditions are satisfied and shareholders approve, the combined company intends to list on Nasdaq under BIOT and BIOTW.